You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR AMLODIPINE BESYLATE AND VALSARTAN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for AMLODIPINE BESYLATE AND VALSARTAN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02060019 ↗ Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects Completed CJ HealthCare Corporation Phase 1 2014-03-01 This study is designated to evaluate the pharmacokinetic interactions of amlodipine besylate, valsartan and rosuvastatin in healthy male volunteers.
NCT02060019 ↗ Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects Completed HK inno.N Corporation Phase 1 2014-03-01 This study is designated to evaluate the pharmacokinetic interactions of amlodipine besylate, valsartan and rosuvastatin in healthy male volunteers.
NCT02069821 ↗ Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects Completed CJ HealthCare Corporation Phase 1 2014-03-01 The purpose of the study is to assess the pharmacokinetic interactions between amlodipine besylate/valsartan and atorvastatin single or co-administered in healthy volunteers.
NCT02069821 ↗ Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects Completed HK inno.N Corporation Phase 1 2014-03-01 The purpose of the study is to assess the pharmacokinetic interactions between amlodipine besylate/valsartan and atorvastatin single or co-administered in healthy volunteers.
NCT03299452 ↗ Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor Unknown status Alphacait, LLC Phase 2 2017-01-01 This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for AMLODIPINE BESYLATE AND VALSARTAN

Condition Name

Condition Name for AMLODIPINE BESYLATE AND VALSARTAN
Intervention Trials
Healthy 2
Metastatic Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for AMLODIPINE BESYLATE AND VALSARTAN
Intervention Trials
Neoplasm Metastasis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for AMLODIPINE BESYLATE AND VALSARTAN

Trials by Country

Trials by Country for AMLODIPINE BESYLATE AND VALSARTAN
Location Trials
Korea, Republic of 2
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for AMLODIPINE BESYLATE AND VALSARTAN

Clinical Trial Phase

Clinical Trial Phase for AMLODIPINE BESYLATE AND VALSARTAN
Clinical Trial Phase Trials
Phase 2 1
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for AMLODIPINE BESYLATE AND VALSARTAN
Clinical Trial Phase Trials
Completed 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for AMLODIPINE BESYLATE AND VALSARTAN

Sponsor Name

Sponsor Name for AMLODIPINE BESYLATE AND VALSARTAN
Sponsor Trials
CJ HealthCare Corporation 2
HK inno.N Corporation 2
Alphacait, LLC 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for AMLODIPINE BESYLATE AND VALSARTAN
Sponsor Trials
Industry 4
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.